MedPath

Neurorehabilitation After Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study

Not Applicable
Recruiting
Conditions
Traumatic Brain Injury
Registration Number
NCT02698449
Lead Sponsor
University Hospital, Toulouse
Brief Summary

The current study aims to better understand cerebral plasticity mechanisms to optimize non-pharmacological rehabilitation approaches for patients with traumatic brain injury.

Detailed Description

Cognitive impairment following moderate to severe traumatic brain injury are usual. To date, cognitive rehabilitation effects on cerebral plasticity and quality of life remain unproven essentially because of methodological biases. Transcranial Direct Current Stimulation is an innovative technique of noninvasive brain stimulation that showed efficacy in literature. The current study want to better understand cerebral plasticity mechanisms to optimize non-pharmacological rehabilitation approaches for patients with traumatic brain injury. The aim in the present study is to assess the effect of rehabilitation combined with Transcranial Direct Current Stimulation provided to traumatic brain injury patients with cognitive impairment on cerebral plasticity using functional magnetic resonance imaging. Effects of rehabilitation and Transcranial Direct Current Stimulation will be observed on functional magnetic resonance imaging activation maps acquired. Relationship between attentional outcomes measured in the neuropsychological assessment and activation extend will be explored.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Moderate to severe traumatic brain injury
  • more than 3 months since the onset
  • Attentional disorders (PASAT test (score ≤ centile 10) and/or CANTAB test (≤ -2 standard deviation)
  • Women having contraceptive treatment (for the magnetic resonance imaging exam)
Exclusion Criteria
  • inability to undergo magnetic resonance imaging scan
  • No attentional impairment (PASAT ≥ centile10)
  • Severe depression
  • Neurological disease
  • Major cognitive impairment (aphasia, neglect)
  • Drugs addiction
  • Pregnant women and women having no contraceptive treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
intergroup difference on cerebral map activation in functional magnetic resonance imaging (N-back task).12 weeks
Secondary Outcome Measures
NameTimeMethod
Intergroup differences in neuropsychological score12 weeks
Intergroup differences in resting activation maps.12 weeks
Correlation between activation extend and attentional outcomes12 weeks
Intergroup differences in diffusion measures12 weeks
Intergroup differences in polymorphisms12 weeks

Trial Locations

Locations (1)

CHU Toulouse

🇫🇷

Toulouse, France

CHU Toulouse
🇫🇷Toulouse, France
Jérémie Pariente, PhD
Contact
0(5).61.77.95.02
pariente.j@chu-toulouse.fr
Emilie Rigal, MD
Contact
(0)5.61.77.57.25
rigal.e@chu-toulouse.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.